Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: billkirn who wrote (3081)	12/2/1997 9:07:00 PM
From: Izzy	Read Replies (1) of 6136

Bill, thanks. The calls look very cheap to me. The issue seems to be the time frame (ie., how far out to go?). John, today I received prescribing info on Viracept from AGPH. Based on your (and others) prior posts and my medical info, I am somewhat confused by the statement: "At present, there are no results from controlled trials evaluating the effect of therapy with VIRACEPT on clinical progression of HIV infection." It doesn't seem that way to me, as I recall. Any comments? Did anyone talk to AGPH IR today?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next